The Glass is Half Full: Smoking cessation for smokers with opioid use disorder, co-hosted by ATTUD

Duration:

60 Minutes

Webinar Speakers

Shadi Nahvi, MD, MS

Associate Professor, Departments of Medicine, and of Psychiatry & Behavioral Sciences, Albert Einstein College of Medicine / Montefiore Health System

Dr. Shadi Nahvi is an Associate Professor in the Departments of Medicine and Psychiatry and Behavioral Sciences at the Albert Einstein College of Medicine, and Co-Director of the General Internal Medicine Fellowship Program. Her research focuses on optimizing quality of life and health outcomes among persons with substance use disorder.

Dr. Nahvi’s research is grounded in over a decade of clinical experience as a primary care physician caring for persons with opioid and other substance use disorders. Her primary research focus is optimizing the efficacy and delivery of tobacco cessation treatments among persons with co-occurring substance use disorders. Currently, she is Principal Investigator of a NIDA R01-funded randomized, 2 x 2 factorial trial of directly observed and long-term varenicline treatment among smokers with opioid use disorder. She has also led a KL2 Career Development Award-funded, randomized, placebo-controlled pilot trial of varenicline for smoking cessation among smokers with co-morbid substance use disorder, a study of health system-level interventions to increase documentation and treatment of tobacco use among substance use disorder counselors, and a randomized trial of the efficacy of directly observed varenicline provided at a methadone clinic for promoting smoking cessation and enhancing adherence.

Dr. Nahvi graduated from the Brown University School of Medicine in 2001 and completed residency training in Primary Care Internal Medicine at Bellevue Hospital and New York University Medical Center in 2004. She then joined the faculty in the Albert Einstein College of Medicine Division of Substance Abuse as the Medical Director of a substance abuse treatment clinic. From 2006-2008, Dr. Nahvi completed a faculty fellowship supported by the Bronx Center to Reduce and Eliminate Ethnic and Racial Health Disparities, a NIH-funded health disparities Center of Excellence. Through this fellowship, she completed the Einstein Clinical Research Training Program and received a MS in Clinical Research Methods.

Dr. Nahvi has served on numerous national advisory committees, including serving as a member of the Advisory Committee of the Society for Research on Nicotine and Tobacco Health Disparities Network, and co-chair of the Evaluation Committee of the Health Disparities Network; a member of the NY State Department of Health AIDS Institute’s Guideline Committee for the Care of Substance Users; and a Steering Committee member of the NY State Department of Health AIDS Institute's Tobacco Cessation Improvement Campaign.

Kimber P. Richter, PhD, MPH, NCTTP

Joy McCann Professor of Women in Medicine & Science, Department of Preventive Medicine and Public Health, University of Kansas School of Medicine

Dr. Richter conducts federally-funded research on tobacco treatment in rural primary care and hospitals and pursues research and advocacy to expand access to high-quality treatment among the medically underserved. She directs UKanQuit at KUMed, a bedside tobacco treatment service for hospital inpatients, which has treated over 20,000 inpatients since 2006. She is an active member of SRNT (the Society for Research on Nicotine and Tobacco) and ATTUD (the Association for the Treatment of Tobacco Use and Dependence) and is former president of the Kansas Public Health Association and the U.S. Association for Medical Education and Research on Substance Abuse (AMERSA). She has a national certificate in tobacco treatment practice (NCTTP) and is certified to deliver the University of Massachusetts Tobacco Treatment Specialist (TTS) training.

Webinar Objectives
  1. Use evidence-based behavioral and pharmacological tobacco cessation treatments

  2. Describe strategies to address tobacco use among persons with opioid use disorder

  3. Optimize cessation treatments to enhance efficacy among persons with opioid use disorder

Instructions for CME/CEU Credit

This CME/CEU registration site has closed. Credit will be available for the recorded webinar by August.

 

ACCREDITATION FOR RESPIRATORY THERAPISTS

 

For CRCE credit, email Jennifer Matekuare with your AARC # and state of residence. This program has been approved for a maximum of 1.0 contact hour Continuing Respiratory Care Education (CRCE) credit by the American Association for Respiratory Care, 9425 N. MacArthur Blvd. Suite 100 Irving TX 75063. Course # 181054000.

 

Certificates of Attendance

Click here to generate your own Certificate of Attendance for this webinar, reflecting one hour of credit.This certificate is best viewed in Adobe Acrobat.

 

ACCME Accreditation

The University of California, San Francisco (UCSF) School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

UCSF designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the webinar activity.

Advance Practice Registered Nurses and Registered Nurses: For the purpose of recertification, the American Nurses Credentialing Center accepts AMA PRA Category 1 CreditTM issued by organizations accredited by the ACCME.

Physician Assistants: The National Commission on Certification of Physician Assistants (NCCPA) states that the AMA PRA Category 1 CreditTM are acceptable for continuing medical education requirements for recertification.

California Pharmacists: The California Board of Pharmacy accepts as continuing professional education those courses that meet the standard of relevance to pharmacy practice and have been approved for AMA PRA category 1 CreditTM. If you are a pharmacist in another state, you should check with your state board for approval of this credit.

California Behavioral Science Professionals: University of California, San Francisco School of Medicine (UCSF) is approved by the California Association of Marriage and Family Therapists to sponsor continuing education for behavioral health providers. UCSF maintains responsibility for this program/course and its content.

Course meets the qualifications for 1.0 hour of continuing education credit for LMFTs, LCSWs, LPCCs, and/or LEPs as required by the California Board of Behavioral Sciences.

Disclosures

This UCSF CME activity was planned and developed to uphold academic standards to ensure balance, independence, objectivity, and scientific rigor; adhere to requirements to protect health information under the Health Insurance Portability and Accountability Act of 1996 (HIPAA); and include a mechanism to inform learners when unapproved or unlabeled uses of therapeutic products or agents are discussed or referenced.

The following speakers, moderators and planning committee members have disclosed they have no financial interest/arrangement or affiliation with any commercial companies who have provided products or services relating to their presentation(s) or commercial support for this continuing medical education activity:

Christine Cheng, Brian Clark, Jennifer Lucero, MA, MS, Jennifer Matekuare, Kimber P. Richter, PhD, MPH, NCTTP, Jessica Safier, MA, Catherine Saucedo, and Steven A. Schroeder, MD

The following faculty speaker has disclosed a financial interest/arrangement or affiliation with a commercial company who has provided products or services relating to their presentation(s) or commercial support for this continuing medical education activity. All conflicts of interest have been resolved in accordance with the ACCME Standards for Commercial Support:

Shadi Nahvi, MD, MS –

  • Pfizer – Grant/Research Support